» Articles » PMID: 15591243

Gastroduodenal Mucus Bicarbonate Barrier: Protection Against Acid and Pepsin

Overview
Specialties Cell Biology
Physiology
Date 2004 Dec 14
PMID 15591243
Citations 150
Authors
Affiliations
Soon will be listed here.
Abstract

Secretion of bicarbonate into the adherent layer of mucus gel creates a pH gradient with a near-neutral pH at the epithelial surfaces in stomach and duodenum, providing the first line of mucosal protection against luminal acid. The continuous adherent mucus layer is also a barrier to luminal pepsin, thereby protecting the underlying mucosa from proteolytic digestion. In this article we review the present state of the gastroduodenal mucus bicarbonate barrier two decades after the first supporting experimental evidence appeared. The primary function of the adherent mucus gel layer is a structural one to create a stable, unstirred layer to support surface neutralization of acid and act as a protective physical barrier against luminal pepsin. Therefore, the emphasis on mucus in this review is on the form and role of the adherent mucus gel layer. The primary function of the mucosal bicarbonate secretion is to neutralize acid diffusing into the mucus gel layer and to be quantitatively sufficient to maintain a near-neutral pH at the mucus-mucosal surface interface. The emphasis on mucosal bicarbonate in this review is on the mechanisms and control of its secretion and the establishment of a surface pH gradient. Evidence suggests that under normal physiological conditions, the mucus bicarbonate barrier is sufficient for protection of the gastric mucosa against acid and pepsin and is even more so for the duodenum.

Citing Articles

Management of gastrointestinal bleed in the intensive care setting, an updated literature review.

Nagesh V, Pulipaka S, Bhuju R, Martinez E, Badam S, Nageswaran G World J Crit Care Med. 2025; 14(1):101639.

PMID: 40060732 PMC: 11671843. DOI: 10.5492/wjccm.v14.i1.101639.


Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy.

Kong C, Yang M, Yue N, Zhang Y, Tian C, Wei D J Inflamm Res. 2024; 17:5389-5413.

PMID: 39161679 PMC: 11330754. DOI: 10.2147/JIR.S470520.


A Novel Characteristic Gastric Mucus Named "Web-like Mucus" Potentially Induced by Vonoprazan.

Kaneko H, Sato H, Suzuki Y, Ikeda A, Kuwashima H, Ikeda R J Clin Med. 2024; 13(14).

PMID: 39064109 PMC: 11277586. DOI: 10.3390/jcm13144070.


Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy.

Yin Q, Ni J, Ying J Immun Inflamm Dis. 2024; 12(7):e1263.

PMID: 39031507 PMC: 11259004. DOI: 10.1002/iid3.1263.


A Model of Gastric Mucosal pH Regulation: Extending Sensitivity Analysis Using Sobol' Indices to Understand Higher Moments.

Aggarwal M, Lewis O, Jarrett A, Hussaini M, Cogan N Bull Math Biol. 2024; 86(7):77.

PMID: 38775877 PMC: 11629775. DOI: 10.1007/s11538-024-01308-x.